(Total Views: 343)
Posted On: 03/30/2021 7:27:59 PM
Post# of 36566
Here is the major thing that Generex / NGIO has going for it right now if it can hurry and get things done - NOW:
With the news that came out recently from a study by military scientists in the VA, that the vaccines on the market only protect around 7 months which is basically the equivalent of if you have had the virus and you have the antibodies, it gives Generex / NGIO the validation of having the 'complete vaccine' which would protect better than anything on the market - period.
So, if they can get this IND done now, get it to the FDA now, and get these phase 1 and 2 done as soon as possible, they win. But if they push everything out and others beat them with a longer protection vaccine, then all bets are off.
This is why they need to do some major marketing to show the world they have the complete vaccine whereas everyone else is really just a yearly shot if it can even be called that.
With the news that came out recently from a study by military scientists in the VA, that the vaccines on the market only protect around 7 months which is basically the equivalent of if you have had the virus and you have the antibodies, it gives Generex / NGIO the validation of having the 'complete vaccine' which would protect better than anything on the market - period.
So, if they can get this IND done now, get it to the FDA now, and get these phase 1 and 2 done as soon as possible, they win. But if they push everything out and others beat them with a longer protection vaccine, then all bets are off.
This is why they need to do some major marketing to show the world they have the complete vaccine whereas everyone else is really just a yearly shot if it can even be called that.
(4)
(0)
